Effect of magnesium sulfate administration for neuroprotection on latency in women with preterm premature rupture of membranes.

Authors

Amanda L. Horton
Yinglei Lai, George Washington UniversityFollow
Dwight J. Rouse
Catherine Y. Spong
Kenneth J. Leveno
+11 additional authors

Document Type

Journal Article

Publication Date

3-2015

Journal

American Journal of Perinatology

Volume

32

Issue

4

Inclusive Pages

387-392

DOI

10.1055/s-0034-1387930

Keywords

Fetal Membranes, Premature Rupture--drug therapy; Magnesium Sulfate--therapeutic use; Neuroprotective Agents--therapeutic use; Tocolytic Agents--therapeutic use

Comments

This is an open access PubMed Central article. Click on link for full-text access.

APA Citation

Horton, A. L., Lai, Y., Rouse, D. J., Spong, C. Y., Leveno, K. J., Varner, M. W., et al. (2015). The effect of magnesium sulfate administration for neuroprotection on latency in women with preterm premature rupture of membranes. American Journal of Perinatology, 32(4), 387–392.

Peer Reviewed

1

Open Access

1